24/06/2020 Clinical study published in Neurology indicates that hormonal changes may contribute to the increased prevalence of Alzheimer’s disease in women Science watch
22/06/2020 Study of post-mortem brain samples shows striking differences in Tau between individuals, contributing to clinical heterogeneity in AD Science watch
17/06/2020 AriBio announces the completion of enrolment of its Phase II trial with AR1001 for AD Science watch
17/06/2020 Pooled study analysis shows how combinations of lifestyle factors may affect Alzheimer’s disease risk Science watch
15/06/2020 Amylyx Pharmaceuticals announces completion of enrolment of its PEGASUS Phase II trial for Alzheimer’s disease Science watch
04/06/2020 Anavex Life Sciences receives regulatory approval to expand its Anavex 2-73 Phase II/III trial for AD in Canada and UK Science watch
29/05/2020 New study reports that nilotinib, an FDA-approved drug for leukaemia, is safe and well-tolerated in AD Phase II trial Science watch
28/05/2020 Neurotrope launches a new long-term clinical trial of Bryostatin-1 in Alzheimer’s disease Science watch
27/05/2020 University of Pittsburgh will use USD 2.6 million NIH award to examine how biological factors affect brain disease Science watch
20/05/2020 TauRx Therapeutics Ltd reports that hydromethylthionine could slow clinical decline and brain atrophy in behavioural variant Fronto-Temporal Dementia Science watch
